1. Home
  2. LVO vs LONA Comparison

LVO vs LONA Comparison

Compare LVO & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveOne Inc.

LVO

LiveOne Inc.

HOLD

Current Price

$6.08

Market Cap

83.7M

ML Signal

HOLD

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$8.35

Market Cap

76.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LVO
LONA
Founded
2009
2011
Country
United States
United States
Employees
N/A
19
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.7M
76.8M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
LVO
LONA
Price
$6.08
$8.35
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$11.50
$10.00
AVG Volume (30 Days)
63.0K
18.8K
Earning Date
06-17-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
78.57
N/A
EPS
N/A
N/A
Revenue
$114,405,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$23.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$4.21
52 Week High
$7.19
$14.21

Technical Indicators

Market Signals
Indicator
LVO
LONA
Relative Strength Index (RSI) 49.60 43.52
Support Level $5.97 $7.99
Resistance Level $7.10 $9.62
Average True Range (ATR) 0.47 0.54
MACD -0.07 -0.02
Stochastic Oscillator 14.49 37.46

Price Performance

Historical Comparison
LVO
LONA

About LVO LiveOne Inc.

LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: